These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 100563)

  • 1. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
    Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
    J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
    Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
    Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis and protective activity of beta-glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine with alkylalicyclic and arylaliphatic aglycons].
    Zemliakov AE; Tsikalova VN; Tsikalov VV; Chirva VIa; Mulik EL; Kaliuzhin OV
    Bioorg Khim; 2005; 31(6):637-44. PubMed ID: 16363137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
    Adam A; Souvannavong V; Lederer E
    Biochem Biophys Res Commun; 1978 Nov; 85(2):684-90. PubMed ID: 367370
    [No Abstract]   [Full Text] [Related]  

  • 5. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Tsujimoto M; Kinoshita F; Okunaga T; Kotani S; Kusumoto S; Yamamoto K; Shiba T
    Microbiol Immunol; 1979; 23(9):933-6. PubMed ID: 576117
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.
    Chedid L; Parant M; Parant F; Lefrancher P; Choay J; Lederer E
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2089-93. PubMed ID: 325566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of nonspecific host resistance to infection induced by muramyldipeptides.
    Matsumoto K; Ogawa H; Nagase O; Kusama T; Azuma I
    Microbiol Immunol; 1981; 25(10):1047-58. PubMed ID: 7031443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of immunostimulant activities of muramyl dipeptide (MDP) by linking amino-acids or peptides to the glutaminyl residue.
    Audibert F; Parant M; Damais C; Lefrancier P; Derrien M; Choay J; Chedid L
    Biochem Biophys Res Commun; 1980 Sep; 96(2):915-23. PubMed ID: 7426019
    [No Abstract]   [Full Text] [Related]  

  • 10. [N-acetylmuramyl-L-alanyl-D-isoglutamine glycosides. Effect of glycoside center configuration and aglycone nature on biological activity].
    Zemliakov AE; Tsikalov VV; Kaliuzhin OV; Kur'ianov VO; Chirva VIa
    Bioorg Khim; 2003; 29(3):316-22. PubMed ID: 12845808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
    Souvannavong V; Adam A
    Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activity of anomeric pairs of lipophilic glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Kalyuzhin OV; Zemlyakov AE; Kalina NG; Mulik EL; Kuzovlev FN; Makarova OV
    Bull Exp Biol Med; 2008 May; 145(5):623-5. PubMed ID: 19145298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.
    Carelli C; Audibert F; Chedid L
    Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
    Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
    J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, mass spectral characterization and immunoadjuvant activity of some novel lipophilic derivatives of muramyl dipeptides.
    Jain RK; Gupta CM; Saxena RK; Saxena RP; Saxena KC; Shukla R; Anand N; Costello CE
    Chem Phys Lipids; 1986; 41(3-4):237-64. PubMed ID: 3815623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP).
    Löwy I; Leclerc C; Bourgeois E; Chedid L
    J Immunol; 1980 Jan; 124(1):320-5. PubMed ID: 6985643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide.
    Parant M; Riveau G; Parant F; Dinarello CA; Wolff SM; Chedid L
    J Infect Dis; 1980 Nov; 142(5):708-15. PubMed ID: 7462686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of endogenous pyrogen-induced fever by a muramyl dipeptide derivative.
    Parant M; Riveau G; Parant F; Chedid L
    Am J Physiol; 1984 Sep; 247(3 Pt 1):C169-74. PubMed ID: 6476105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiators.
    Audibert F; Chedid L
    Prog Clin Biol Res; 1980; 47():325-38. PubMed ID: 7010376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.